Biogen Drugs - 搜索图片

1200 x 800 · jpeg
bloomberg.com
Biogen Drops After Alzheimer's Drug Trial Change Raises Concerns ...
872 x 798 · png
seekingalpha.com
Biogen: An Uphill Battle Looms (NASDAQ:BIIB) | …
1:51
finance.yahoo.com > Yahoo Finance Video
Eisai-Biogen's Alzheimer's treatment drug receives FDA approval
2000 x 1262 · jpeg
thehealthcaretechnologyreport.com
Biogen Seeks Approval For New Alzheimer’s Drug | The Healthcare ...

1024 x 576 · jpeg
STAT
I used to work on Biogen’s Alzheimer’s drug. Is it spinning bad data?
1024 x 682 · jpeg
pbs.org
Biogen cuts the price tag on its Alzheimer’s drug in half | PBS N…
2508 x 1411 · jpeg
geneonline.com
FDA Grants Biogen’s Ultra-Rare ALS Med Accelerated Approval ...
1024 x 628 · jpeg
Time
Biogen Explains Its Alzheimer’s Drug Reversal | TIME

1200 x 630 · jpeg
siliconvalleyjournals.com
Biogen Announces Layoffs at Reata Pharmaceuticals Following $7B Acquisition
4236 x 2824 · jpeg
bloomberg.com
FDA Restriction of Biogen Alzheimer’s Drug Raises Quest…
1200 x 676 · jpeg
bizjournals.com
Biogen shares jump despite mixed news on rare disease drugs - Boston ...
1200 x 677 · jpeg
bizjournals.com
Biogen's Alzheimer's drug shows promise, FDA officials say - Triangle ...

2048 x 1365 · jpeg
nytimes.com
Biogen’s Alzheimer’s drug is unlikely to win E.U. approval. - The New ...
1200 x 800 · jpeg
bloomberg.com
How Biogen (BIIB) Salvaged Its Alzheimer’s Drug - Bloomberg
3000 x 1688 · jpeg
businesspost.ie
Biogen to urgently appeal court judgment allowing generic MS drug ...
700 x 466 · jpeg
wsj.com
Biogen to Lay Off Roughly 11% of Workforce to Focus on Big-Return …

2000 x 1333 · jpeg
nypost.com
FDA approves Biogen's Alzheimer's drug
1200 x 1200 · jpeg
livingfit.co.za
Biogen Complete Whey - 875g - Dis-Chem Living Fit
750 x 563 · jpeg
europeanpharmaceuticalreview.com
Biogen to acquire rare disease drugmaker for $7.3b
1350 x 900 · jpeg
kffhealthnews.org
Facing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial ...

1000 x 563 · jpeg
investors.com
Biogen Stock And Aducanumab: What This Alzheimer's Treatment Means For ...
1523 x 1800 · jpeg
The Boston Globe
Biogen suffers setback in patent d…
960 x 640 · jpeg
bloomberg.com
Biogen (BIIB) Alzheimer’s Drug Aduhelm Shows Brain Swelling in 35…
860 x 573 · jpeg
wsj.com
Despite Pressure, Biogen’s Alzheimer’s Drug Still a Likely Blockbuster ...

3219 x 2388 · jpeg
The Boston Globe
Biogen wins FDA approval on new multiple sclerosis drug - The Bo…
1920 x 1080 · jpeg
cnbc.com
Biogen's Alzheimer's drug could cost Medicare billions of dollars a ...
1280 x 853 · jpeg
bostonglobe.com
‘It’s night and day’: Biogen’s new Alzheimer’s drug may spur more ...
1200 x 800 · jpeg
drugdiscoverytrends.com
Biogen to Spin Off Hemophilia Unit, Focus on Neurodegenerative Drugs ...

860 x 573 · jpeg
wsj.com
Biogen Details Case for Controversial Alzheimer’s Drug - WSJ
960 x 640 · jpeg
bloomberg.com
Biogen ALS Drug Wins US Approval to Treat Rare Form of Disease - Bl…
1920 x 1281 · jpeg
biovox.eu
Biogen’s controversial Alzheimer’s drug approved by the FDA – what …
1200 x 675 · png
wcvb.com
Cambridge-based Biogen's controversial Alzheimer’s drug wins FDA approval

1920 x 1080 · jpeg
cnbc.com
Biogen faces tough questions on $56K-a-year price of new Alzheimer's drug
1200 x 800 · jpeg
reuters.com
Biogen trial of ALS drug fails main goal, but company says data are ...
3000 x 1852 · jpeg
foxbusiness.com > Fox Business
Biogen's Alzheimer's drug hits detour and puts FDA approval in doubt ...

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果